Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2021 Aug 16;36(2):176–179. doi: 10.1097/WAD.0000000000000474

Table 1.

Performance of different models in prediction of progression from aMCI to dementia.

Feature- set Model Follow-up, years Sensitivity, %, 95% CI Specificity, %, 95% CI PPV,
%, 95% CI
NPV,
%, 95% CI
Accuracy,
%, 95% CI
AUC Progression rate, %a N
1 Index 0.5 46.6 87.6 20.2 96.0 85.0 0.67 6.3 475
1 41.7 90.4 42.4 90.1 83.3 0.66 14.5 463
2 32.6 94.9 69.3 80.2 78.9 0.64 25.8 403
3 28.8 97.5 82.3 77.8 78.2 0.63 28.1 345
4 26.6 99.3 95.2 74.6 76.4 0.63 31.5 238
LR 0.5 93.3
(77.9–99.1)
60.0
(55.3–64.5)
13.5
(11.9–15.4)
99.2
(97.2–99.8)
62.1
(57.6–66.4)
0.77 6.3 475
1 88.0
(77.8–94.7)
65.1
(60.2–69.8)
29.9
(26.7–33.4)
96.9
(94.4–98.4)
68.4
(64.0–72.7)
0.77 14.5 463
2 80.7
(71.8–87.8)
73.9
(68.5–78.8)
51.8
(46.5–57.1)
91.7
(88.1–94.3)
75.6
(71.2–79.8)
0.77 25.8 403
3 76.2
(66.6–84.3)
79.0
(73.4–83.9)
58.7
(52.1–65.0)
89.5
(85.5–92.4)
78.2
(73.5–82.5)
0.78 28.1 345
4 77.3
(66.2–86.2)
85.2
(78.9–90.3)
70.7
(62.1–78.1)
89.1
(84.3–92.6)
82.7
(77.4–87.3)
0.81 31.5 238
ELD 0.5 83.3
(65.3–94.4)
72.3
(68.0–76.4)
16.8
(14.0–20.2)
98.4
(96.6–99.3)
73.0
(68.8–77.0)
0.78 6.3 475
1 76.1
(64.1–85.7)
77.2
(72.8–81.3)
36.1
(31.1–41.5)
95.0
(92.5–96.7)
77.1
(73.0–80.9)
0.77 14.5 463
2 68.2
(58.4–77.0)
84.9
(80.4–88.8)
61.2
(53.9–68.0)
88.5
(85.3–91.1)
80.6
(76.4–84.4)
0.77 25.8 403
3 65.9
(55.6–75.3)
90.3
(85.9–93.7)
72.7
(64.0–80.0)
87.1
(83.7–90.0)
83.4
(79.1–87.2)
0.78 28.1 345
4 58.6
(46.7–69.9)
93.8
(89.0–97.0)
81.4
(70.0–89.2)
83.1
(79.0–86.6)
82.7
(77.3–87.3)
0.76 31.5 238
2 LR
0.5 53.3
(34.3–71.6)
83.1
(79.3–86.5)
17.5
(12.5–24.0)
96.3
(94.7–97.4)
81.2
(77.4–84.7)
0.68 6.3 475
1 35.8
(24.5–48.5)
83.5
(79.6–87.1)
26.9
(20.0–35.3)
88.5
(86.5–90.2)
76.6
(72.5–80.4)
0.60 14.5 463
2 38.4
(29.0–48.5)
90.3
(86.4–93.4)
57.9
(47.5–67.8)
80.8
(78.3–83.1)
76.9
(72.5–81.0)
0.64 25.8 403
3 38.1
(28.5–48.5)
93.5
(89.7–96.2)
69.8
(57.5–79.8)
79.4
(76.7–81.9)
77.9
(73.2–82.2)
0.66 28.1 345
4 34.6
(24.0–46.5)
94.4
(89.8–97.4)
74.2
(25.6–37.8)
75.8
(58.8–85.4)
75.6
(72.6–78.8)
0.65 31.5 238
ELD 0.5 86.6
(69.3–96.2)
64.4
(59.8–68.9)
14.1
(12.0–16.6)
98.6
(96.6–99.4)
65.8
(61.4–70.1)
0.76 6.3 475
1 85.0
(74.2–92.6)
69.1
(64.4–73.7)
31.8
(28.1–35.8)
96.4
(93.9–98.0)
71.4
(67.1–75.6)
0.77 14.5 463
2 80.7
(71.9–87.8)
78.6
(73.5–83.1)
56.7
(21.6+30.4)
92.1
(88.7–94.6)
79.1
(74.9–83.0)
0.80 25.8 403
3 79.3
(70.0–86.9)
86.2
(81.4–90.3)
69.3
(62.0–75.9)
91.4
(87.8–94.0)
84.3
(80.1–88.0)
0.83 28.1 345
4 68.0
(56.2–78.3)
90.1
(84.5–94.3)
76.1
(66.1–83.9)
85.9
(81.4–89.5)
83.1
(77.8–87.7)
0.79 31.5 238

Note.

a

Represents progression rate from aMCI to AD at each follow up timeframe based on longitudinal data, which is included in the table for the purpose of comparison with PPV/NPV derived from the models. See texts for details on variables included in each feature-set.

Abbreviations: N= Number of participants at each follow up; LR= logistic regression; ELD= ensemble linear discriminant; CI= confidence interval; PPV= positive predictive value; NPV = negative predictive value.